Literature DB >> 25837427

Large-Scale Persistent Network Reconfiguration Induced by Ketamine in Anesthetized Monkeys: Relevance to Mood Disorders.

Qian Lv1, Liqin Yang1, Guoliang Li2, Zhiwei Wang1, Zhuangming Shen1, Wenwen Yu1, Qinying Jiang1, Baoyu Hou1, Jian Pu1, Hailan Hu1, Zheng Wang3.   

Abstract

BACKGROUND: Ketamine is a highly attractive candidate for developing fast-onset antidepressant agents; however, the relevant brain circuits that underlie sustained, efficacious antidepressant effects remain largely unknown.
METHODS: We used a holistic scheme combining whole-brain resting-state fMRI and graph theoretical analysis to examine the sustained effects on brain networks after administration of a single dose of ketamine and to identify the brain regions and circuits preferentially targeted by ketamine. Topological differences in functional networks of anesthetized macaque monkeys were compared between ketamine (.5 mg/kg) and saline treatment after 18 hours.
RESULTS: We observed persistent global reconfiguration of small-world properties in response to ketamine intake, accompanied by large-scale downregulation of functional connectivity, most prominently in the orbital prefrontal cortex, the subgenual and posterior cingulate cortices, and the nucleus accumbens. Intriguingly, intrinsic connectivity with the medial prefrontal areas in the reward circuits were selectively downregulated. Global and regional regulations of the brain networks precisely opposed the maladaptive alterations in the depressed brain.
CONCLUSIONS: Our results demonstrated that local synaptic plasticity triggered by blockade of N-methyl-D-aspartic acid receptors was capable of translating into prolonged network reconfiguration in the distributed cortico-limbic-striatal circuit, providing mechanistic insight into developing specific loci or circuit-targeted, long-term therapeutics.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional connectivity; Graph theory; Ketamine; Macaque monkey; Mood disorders; Neural network plasticity

Mesh:

Substances:

Year:  2015        PMID: 25837427     DOI: 10.1016/j.biopsych.2015.02.028

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  28 in total

1.  The best defense is a strong offense: preventing alcohol abstinence-induced depression.

Authors:  Kara K Cover; Willa G Kerkhoff; Brian N Mathur
Journal:  Neuropsychopharmacology       Date:  2018-07-30       Impact factor: 7.853

2.  Connectomic Underpinnings of Working Memory Deficits in Schizophrenia: Evidence From a replication fMRI study.

Authors:  Jie Yang; Weidan Pu; Guowei Wu; Eric Chen; Edwin Lee; Zhening Liu; Lena Palaniyappan
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

3.  Serial Prefrontal Pathways Are Positioned to Balance Cognition and Emotion in Primates.

Authors:  Mary Kate P Joyce; Miguel Ángel García-Cabezas; Yohan J John; Helen Barbas
Journal:  J Neurosci       Date:  2020-09-28       Impact factor: 6.167

Review 4.  From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.

Authors:  Urs Braun; Axel Schaefer; Richard F Betzel; Heike Tost; Andreas Meyer-Lindenberg; Danielle S Bassett
Journal:  Neuron       Date:  2018-01-03       Impact factor: 17.173

5.  Data-Driven Subgroups in Depression Derived from Directed Functional Connectivity Paths at Rest.

Authors:  Rebecca B Price; Kathleen Gates; Thomas E Kraynak; Michael E Thase; Greg J Siegle
Journal:  Neuropsychopharmacology       Date:  2017-05-12       Impact factor: 7.853

Review 6.  Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action.

Authors:  Eric A Maltbie; Gopinath S Kaundinya; Leonard L Howell
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

Review 7.  Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.

Authors:  Samuel T Wilkinson; Paul E Holtzheimer; Shan Gao; David S Kirwin; Rebecca B Price
Journal:  Biol Psychiatry       Date:  2018-09-20       Impact factor: 13.382

Review 8.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

9.  Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.

Authors:  Meng Li; Marie Woelfer; Lejla Colic; Adam Safron; Catie Chang; Hans-Jochen Heinze; Oliver Speck; Helen S Mayberg; Bharat B Biswal; Giacomo Salvadore; Anna Fejtova; Martin Walter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-10-23       Impact factor: 5.270

Review 10.  Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.

Authors:  Faryal Mallick; Cheryl B McCullumsmith
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.